May 12, 2022 / 05:00PM GMT
Tazeen Ahmad - Bank of America Merrill Lynch - Analyst
(audio in progress) everybody, good morning. Welcome to the Bank of America Healthcare Conference. I am Tazeen Ahmad, I am one of the senior SMID biotech analysts here at the bank. It is my pleasure to have our next presenting company with us, Pharvaris. Sitting up here with me are team members from the management team. We've got Chief Executive Officer, Berndt Modig; as well as Morgan Conn who is Chief Business Officer.
Questions and Answers:
Tazeen Ahmad - Bank of America Merrill Lynch - AnalystSo let's start off, maybe, Berndt, if you could give us a couple of minute overview of the company, your platform, your areas of focus, and then we can go into a little bit more detailed Q&A if that works.
Berndt Modig - Pharvaris N.V. - CEO, Director
Sure, yeah. Absolutely. So yeah. Thanks and good to be here today. And thanks for coming to listen to our story about Pharvaris. Pharvaris is a clinical-stage company, and we are working on improving therapies and
Trustpilot
